drugset / Trial / NCT07377656
Strengthening HPV Immunization Through EPI Leveraged Delivery
Phase 2
Recruiting
115 enrolled
International Vaccine Institute
Dodowa Health Research Centre · collabKarolinska Institutet · collabNoguchi Memorial Institute for Medical Research · collab
RandomizedSequentialQuadruple-blindPrevention
Summary
This is a randomized observer-blind placebo-controlled proof-of-concept study with the aim to assess the safety and tolerability, and the immunogenicity of a bivalent HPV vaccine administered in healthy infants and toddlers (9- and 15-month-olds) comparing them to an immune-bridging population of 15-20-year-old unmarried females in an open label study in Ghana at the Dodowa Health Research Center.
Timeline
- Start
- 2026-04-30
- Primary completion
- 2028-02-29
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cecolin | Vaccine | 0.5 ml | Intramuscular |
| Background | Measles and rubella Vaccine | Vaccine | — | — |
Indications
No indication recorded.